Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00995761
What this trial is testing

Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Gyeongsang National University Hospital 48
Not applicableLooking for participantsNCT06962670
What this trial is testing

Predicting Cancer Risk With Digital and Molecular Markers

Who this might be right for
Breast CancerLung CancerColorectal Cancer+1 more
University of Erlangen-Nürnberg Medical School 1,250
Not applicableActive Not RecruitingNCT07312682
What this trial is testing

Application of 4DCT-Based Pulmonary Ventilation Imaging in Lung Cancer Radiotherapy

Who this might be right for
Lung NeoplasmsRadiation Pneumonitis
The Second Affiliated Hospital of Chongqing Medical University 202
Testing effectiveness (Phase 2)Study completedNCT00003158
What this trial is testing

S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 96
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07274384
What this trial is testing

Hyperprogression in PD-L1 ≥ 50% NSCLC: a Biomarker Guided Phase 2 Trial

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Hyperprogression
Università Vita-Salute San Raffaele 74
Not applicableNot Yet RecruitingNCT07553598
What this trial is testing

AIRCARE (Air Pollution and Cancer Research Ecosystem): Center for Advanced Research on Environmental Health and Lung Cancer Risk

Who this might be right for
Lung Cancer
All India Institute of Medical Sciences 3,230
Not applicableStudy completedNCT03924206
What this trial is testing

Hazardous Surgical Smoke: Risk Assessment and Evaluation of a New Smoke Extractor System in the Surgical Unit

Who this might be right for
Lung CancerLung Injury
Insel Gruppe AG, University Hospital Bern 142
Post-approval studies (Phase 4)Study completedNCT03469271
What this trial is testing

Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients

Who this might be right for
Cancer
Mayo Clinic 63
Not applicableUnknownNCT00006087
What this trial is testing

Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer

Who this might be right for
Lung Cancer
Jewish Hospital and St. Mary's Healthcare
Early research (Phase 1)Study completedNCT02960594
What this trial is testing

HTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

Who this might be right for
Breast CancerLung CancerPancreatic Cancer+6 more
Inovio Pharmaceuticals 93
Not applicableStudy completedNCT05787522
What this trial is testing

Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk

Who this might be right for
Lung CancerBreast CancerEsophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 500
Testing effectiveness (Phase 2)UnknownNCT01823003
What this trial is testing

Risk Adapted SABR(SABR) in Stage I NSCLC And Lung Metastases

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasm Metastasis
Institut Català d'Oncologia 67
Not applicableEnrolling By InvitationNCT05627674
What this trial is testing

Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment

Who this might be right for
SmokingSmoking CessationTobacco Use Cessation
Washington University School of Medicine 915
Not applicableStudy completedNCT02728596
What this trial is testing

S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

Who this might be right for
Febrile NeutropeniaStage 0 Breast CancerStage 0 Colorectal Cancer+25 more
SWOG Cancer Research Network 3,665
Not applicableNot Yet RecruitingNCT07727122
What this trial is testing

Multicenter Prospective Validation of AI Models for Malignancy Risk Prediction in Pulmonary Nodules

Who this might be right for
Pulmonary Nodules
Guangdong Provincial People's Hospital 3,000
Not applicableStudy completedNCT01176383
What this trial is testing

Impact of a Gene Test for Susceptibility to Lung Cancer in Smokers

Who this might be right for
Smoking Cessation
Sussex NHS Research Consortium 67
Large-scale testing (Phase 3)Active Not RecruitingNCT06564844
What this trial is testing

A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 25
Not applicableEnrolling By InvitationNCT07216144
What this trial is testing

Centralized Lung Cancer Screening Engagement in At-Risk Populations

Who this might be right for
Lung Cancer Screening
Weill Medical College of Cornell University 2,000
Not applicableNot Yet RecruitingNCT07752966
What this trial is testing

Evaluation of a Genetic Risk Score for Lung Metastasis and Prognosis in Breast Cancer

Who this might be right for
Breast Cancer Lung Metastasis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 330
Not applicableLooking for participantsNCT05587439
What this trial is testing

Investigating Hereditary Risk In Thoracic Cancers (INHERIT)

Who this might be right for
Lung CancerGenetic DiseaseGenetic Predisposition+1 more
Dana-Farber Cancer Institute 500
Next Page